L'Oreal says weight loss drugs are impacting beauty and skincare sales
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us".
Story summary
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us".
Follow the latest stories from trusted publishers with concise summaries. Open the original source link for details.